Antiphospholipidic Antibodies in SARS-CoV2 Infection: Still a Lot to Learn

1. Dima A, Moroti RV, Popescu DN, Berza I, Parvu DA, Dumitrescu B. Anticardiolipin antibodies in COVID-19 report of three cases. Internal Medicine (Medicina Interna) 2021; in press.10.2478/inmed-2021-0151Search in Google Scholar

2. Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, et al.Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med 2020;382(17):e38.10.1056/NEJMc2007575716126232268022Search in Google Scholar

3. Bowles L, Platton S, Yartey N, Dave M, Lee K, Hart DP, et al. Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19. N Engl J Med2020;383(3):288-290.10.1056/NEJMc2013656721755532369280Search in Google Scholar

4. Le Joncour A, Frere C, Martin-Toutain I, Gougis P, Ghillani-Dalbin P, Maalouf G, et al. Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine ward. Autoimmun Rev 2020;102729.doi: 10.1016/j.autrev.2020.102729.10.1016/j.autrev.2020.102729783418733321245Search in Google Scholar

5. Pineton de Chambrun M, Frere C, Miyara M, Amoura Z, Martin-Toutain I, et al. High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability? J Intern Med 2020;10.1111/joim.13126.10.1111/joim.13126730703232529774Search in Google Scholar

6. Bertin D, Brodovitch A, Beziane A, Hug S, Bouamri A, Mege JL, et al. Anticardiolipin IgG Autoantibody Level Is an Independent Risk Factor for COVID-19 Severity. Arthritis Rheumatol 2020;72(11):1953-1955.10.1002/art.41409732309132564467Search in Google Scholar

7. XiaoM, Zhang Y, Zhang S, Qin X, Xia P, Cao W, et al. Antiphospholipid Antibodies in Critically Ill Patients With COVID-19. Arthritis Rheumatol. 2020;72(12):1998-2004.10.1002/art.41425736193232602200Search in Google Scholar

8. Galeano-Valle F, Oblitas CM, Ferreiro-Mazón MM, Alonso-Muñoz J, Del Toro-Cervera J, di Natale M, et al. Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism. Thromb Res 2020;192:113-115.10.1016/j.thromres.2020.05.017722749632425261Search in Google Scholar

9. Gkrouzman E, Barbhaiya M, Erkan D, Lockshin MD. Reality check on antiphospholipid antibodies in COVID-19-associated coagulopathy. Arthritis Rheumatol. 2020 Jul 31.doi: 10.1002/art.41472. Online ahead of print.10.1002/art.4147232901454Search in Google Scholar

10. Schouwers SM, Delanghe JR, Devreese KM. Lupus Anticoagulant (LAC) testing in patients with inflammatory status: does C-reactive protein interfere with LAC test results? Thromb Res 2010;125:102104.Search in Google Scholar

11. Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 2019;78:1296-1304.10.1136/annrheumdis-2019-21521331092409Search in Google Scholar